series-c-plus
Stage
2
Investors
About
Nanologica develops and manufactures advanced chromatography media (silica-based resins) for purification of pharmaceutical substances, with a focus on peptide drugs. The group also includes Syntagon, a contract manufacturer for drug molecules, and the company is listed on Nasdaq Stockholm (ticker NICA).
Explore Nanologica's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.